secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECIGEN, INC. (PGEN)
CIK:        0001356090
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001104659-25-079497
Event type: regulatory
Sentiment:  positive
Materiality: 0.90
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precigen announces FDA approval of PAPZIMEOS (no further details)
-----------------------------------------------------------------

- US FDA approval of PAPZIMEOS announced via slide deck at August 18, 2025 investor webcast.
- No additional specifics such as indication or market size provided in this filing.
- The approval represents a significant regulatory milestone for Precigen (PGEN).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356090/000110465925079497/0001104659-25-079497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356090/000110465925079497/tm2523710d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-079497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer